Languages and formats The 2026 Prohibited List, the 2026 Summary of Modifications and Explanatory Notes, and the 2026 Monitoring Program are available for download on WADAs website in English, French, and Spanish
Semaglutide is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management
Am I a candidate for the DreamShape GLP-1 Weight Loss Program
A New Use for Wegovy Opens the Door to Medicare Coverage for Millions of People with Obesity The FDA recently approved a new use for Wegovy (semaglutide), the blockbuster anti-obesity drug, to reduce the risk of heart attacks and stroke in people with cardiovascular disease who are overweight or obese
Drink before meals to block carbs & naturally boost your GLP-1
Conclusion Retatrutide stands out as one of the most promising new peptides currently under research, thanks to its triple-receptor mechanism targeting GLP-1, GIP, and glucagon pathways